JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4401
Citizens
CIA
$181M
| $100K | ﹤0.01% |
16,679
+445
| +3% | +$2.56K |
2017 Q4
10 quarters
|
|
|
AAIC
4402
DELISTED
Arlington Asset Investment Corp.
AAIC
| $100K | ﹤0.01% |
33,878
-158,291
| -82% | -$424K |
2013 Q2
28 quarters
|
|
|
FLY
4403
DELISTED
Fly Leasing Limited
FLY
| $100K | ﹤0.01% |
12,208
-83,090
| -87% | -$579K |
2018 Q2
8 quarters
|
|
4404
Franklin Financial Services
FRAF
$283M
| $99K | ﹤0.01% |
3,829
-3,267
| -46% | -$84.4K |
2019 Q2
4 quarters
|
|
4405
CALL
Mercado Libre
MELI
$94.7B
| $99K | ﹤0.01% |
100
| – | – |
2020 Q1
1 quarter
|
|
|
ORGS
4406
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $99K | ﹤0.01% |
+1,623
| New | +$98.2K |
2020 Q2
0 quarters
|
|
4407
CALL
Philip Morris
PM
$295B
| $98K | ﹤0.01% |
+1,400
| New | +$102K |
2020 Q2
0 quarters
|
|
4408
Unity Bancorp
UNTY
$550M
| $98K | ﹤0.01% |
6,868
-6,894
| -50% | -$94.3K |
2017 Q4
10 quarters
|
|
|
ASPU
4409
DELISTED
ASPEN GROUP, INC.
ASPU
| $98K | ﹤0.01% |
+10,827
| New | +$89K |
2020 Q2
0 quarters
|
|
|
FRBK
4410
DELISTED
Republic First Bancorp Inc
FRBK
| $97K | ﹤0.01% |
40,189
-16,410
| -29% | -$37.8K |
2017 Q4
10 quarters
|
|
|
PBIP
4411
DELISTED
Prudential Bancorp, Inc.
PBIP
| $97K | ﹤0.01% |
8,089
-7,468
| -48% | -$88.8K |
2017 Q4
10 quarters
|
|
4412
Arcutis Biotherapeutics
ARQT
$3.16B
| $96K | ﹤0.01% |
3,199
-152
| -5% | -$4.39K |
2020 Q1
1 quarter
|
|
|
IBDQ
4413
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $96K | ﹤0.01% |
3,546
+3,350
| +1,709% | +$87.9K |
2019 Q4
2 quarters
|
|
4414
Nature's Sunshine
NATR
$219M
| $96K | ﹤0.01% |
10,580
-5,012
| -32% | -$43.5K |
2016 Q4
14 quarters
|
|
4415
Pioneer Bancorp
PBFS
$420M
| $96K | ﹤0.01% |
10,532
-8,348
| -44% | -$77.9K |
2019 Q3
3 quarters
|
|
4416
Regional Management Corp
RM
$299M
| $96K | ﹤0.01% |
5,453
-41,563
| -88% | -$649K |
2016 Q4
14 quarters
|
|
|
ICBK
4417
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $96K | ﹤0.01% |
+4,600
| New | +$93.8K |
2020 Q2
0 quarters
|
|
4418
Eastern Company
EML
$154M
| $95K | ﹤0.01% |
5,354
-3,886
| -42% | -$71.1K |
2017 Q4
10 quarters
|
|
4419
PUT
Gogo Inc
GOGO
$281M
| $95K | ﹤0.01% |
30,000
+10,000
| +50% | +$21.5K |
2020 Q1
1 quarter
|
|
4420
GeoPark
GPRK
$738M
| $95K | ﹤0.01% |
+9,741
| New | +$87.4K |
2020 Q2
0 quarters
|
|
4421
Tidewater
TDW
$4.23B
| $95K | ﹤0.01% |
17,041
+368
| +2% | +$2.09K |
2013 Q2
28 quarters
|
|
4422
Verastem
VSTM
$724M
| $95K | ﹤0.01% |
+4,586
| New | +$121K |
2020 Q2
0 quarters
|
|
|
CSLT
4423
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $95K | ﹤0.01% |
114,827
-341,584
| -75% | -$254K |
2017 Q4
10 quarters
|
|
4424
Aprea Therapeutics
APRE
$8.4M
| $94K | ﹤0.01% |
121
-34
| -22% | -$22.3K |
2019 Q4
2 quarters
|
|
|
ITIC
4425
Investors Title Co
ITIC
$554M
| $94K | ﹤0.01% |
783
-1,966
| -72% | -$245K |
2017 Q3
11 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.